Illumina | ILMN - Assets


Illumina reported $6.81B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Agilent USD 13.97B 902M Jun/2026
Bio Techne USD 2.64B 50.09M Sep/2026
Bio-Rad Laboratories USD 10.78B 531.1M Sep/2026
Boston Scientific USD 45.46B 245M Sep/2026
Bruker USD 5.83B 224.6M Sep/2026
Charles River Laboratories USD 7.45B 80.64M Sep/2026
Danaher USD 93.28B 914M Sep/2026
Dentsply International USD 5.19B 14M Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Illumina USD 6.81B 162M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Laboratory Of America USD 18.92B 392.3M Sep/2026
Mettler Toledo International USD 3.7B 24.53M Sep/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Pacific Biosciences Of California USD 721.1M 30.75M Sep/2026
Quest Diagnostics USD 17.22B 282M Sep/2026
Quidel USD 5.78B 66M Sep/2026
Repligen USD 2.93B 23.77M Sep/2026
Revvity USD 11.49B 555.49M Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Standard Biotools USD 635.33M 8.11M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Waters USD 24.12B 636M Sep/2026